Objective:To identify the multidimensional health management needs of young and middle-aged women with breast cancer based on a patient journey map, with the aim of improving prognosis and quality of life in this population.Methods:A descriptive qualitative research approach was employed. From November 2024 to February 2025, in-depth interviews were conducted with 20 young and middle-aged female patients undergoing treatment for breast cancer at the First Affiliated Hospital of Nanjing Medical University. Data were analyzed using conventional content analysis, and a patient journey map was developed.Results:Along the treatment timeline, patients' health management needs were categorized and refined from three dimensions—tasks, pain points, and emotions—into key themes: limited disease awareness, need for early detection and treatment, decision on the treatment plane, lack of nutritional support, impairment of intimate relationships and impact on fertility, body image and self-identity, and coping with changes in social relationships. These findings were integrated into a visualized patient journey map.Conclusions:The health management journey of young and middle-aged women with breast cancer is long and deeply personal, characterized by complex and diverse needs. The patient journey map systematically illustrates patients' dynamic experiences, perceptions, and behaviors as they interact with multiple events, changing environments, and varied healthcare services. It also reveals the internal drivers behind decision-making processes, uncovering unmet needs that may not be readily apparent. This process enables healthcare professionals to adopt a patient-centered approach to innovatively optimize interventions, thereby improving the precision and appropriateness of healthcare services.

Objective:To investigate the short-term efficacy and safety of rituximab (RTX) in children with calcineurin inhibitor (CNI) resistant steroid resistant nephrotic syndrome (SRNS).Methods:A retrospective case analysis was conducted. Thirteen children with CNI resistant SRNS who were regularly treated with RTX (375 mg/m 2 per dose (maximum dose 500 mg), 1 dose per week, a total of 4 doses) in Department of Nephrology, Children′s Hospital of Fudan University from January 2016 to December 2023 were enrolled. The general data, disease related information, urinary protein/creatinine, serum albumin, blood creatinine before RTX treatment, immunosuppressants, adverse events, and monthly urinary protein/creatinine, serum albumin, and blood creatinine indexes within 6 months after RTX treatment were collected. The changes of urinary protein/creatinine, serum albumin and estimated glomerular filtration rate (eGFR) before and after RTX at 3 and 6 months were analyzed by using paired sample t test and Wilcoxon signed-rank test. Results:Among the 13 patients, 8 were male and 5 were female. The age of disease onset was 4.0 (2.9, 6.8) years and the age of RTX treatment was 9.8 (5.9, 13.6) years. There were 8 cases of focal segmental glomerulosclerosis, 3 cases of minimal change disease and 2 cases of mesangial proliferative glomerulonephritis. No clinically significant gene variation was detected in 12 cases and the other one did not receive gene test. Before RTX treatment, 11 cases were in chronic kidney disease stage G1, and 1 case each was in stage G2 and stage G3. Ten children completed 4 doses of RTX treatment, 1 patient completed 3 doses, and 2 patients completed 2 doses. Urinary protein/creatinine in 13 children at 3 and 6 months after RTX treatment was significantly lower than baseline (0.60 (0.13, 2.04), 0.49 (0.28, 1.10) vs. 1.44 (0.76, 4.11) mg/mg, Z=-2.34, -2.34, both P<0.05), and serum albumin was significantly higher than baseline ((35±8), (34±7) vs. (30±6) g/L, t=2.30, 2.60, both P<0.05). The eGFR at 6 months after RTX treatment was not significantly different from the baseline ((110±32) vs. (113±35) ml/(min·1.73 m 2), t=-0.76, P>0.05)). No serious adverse reactions occurred in this study. Conclusion:RTX could reduce urinary protein and increase serum albumin in short-term treatment in children with CNI resistant SRNS without significant side effects.

Objective:To identify the multidimensional health management needs of young and middle-aged women with breast cancer based on a patient journey map, with the aim of improving prognosis and quality of life in this population.Methods:A descriptive qualitative research approach was employed. From November 2024 to February 2025, in-depth interviews were conducted with 20 young and middle-aged female patients undergoing treatment for breast cancer at the First Affiliated Hospital of Nanjing Medical University. Data were analyzed using conventional content analysis, and a patient journey map was developed.Results:Along the treatment timeline, patients' health management needs were categorized and refined from three dimensions—tasks, pain points, and emotions—into key themes: limited disease awareness, need for early detection and treatment, decision on the treatment plane, lack of nutritional support, impairment of intimate relationships and impact on fertility, body image and self-identity, and coping with changes in social relationships. These findings were integrated into a visualized patient journey map.Conclusions:The health management journey of young and middle-aged women with breast cancer is long and deeply personal, characterized by complex and diverse needs. The patient journey map systematically illustrates patients' dynamic experiences, perceptions, and behaviors as they interact with multiple events, changing environments, and varied healthcare services. It also reveals the internal drivers behind decision-making processes, uncovering unmet needs that may not be readily apparent. This process enables healthcare professionals to adopt a patient-centered approach to innovatively optimize interventions, thereby improving the precision and appropriateness of healthcare services.

Objective:To investigate the efficacy and safety of allopurinol in stable coronary heart disease patients with asymptomatic hyperuricemia (AH).Methods:Sixty stable coronary heart disease with AH patients admitted to the Changsha Third Hospital from January 2022 to December 2023 were selected. Patients were randomly divided into an observation group (allopurinol treatment group) and a control group (placebo group). The results of tablet exercise tests, treatment efficacy, blood uric acid levels, liver and kidney function indicators, and incidence of adverse events were compare and analyzed between two groups of patients.Results:The observation group had better exercise termination time, maximum ST descent time, and ST recovery time than the control group (all P<0.05). The total effective rate of the observation group after 6 weeks of treatment was significantly higher than that of the control group, and the difference was statistically significant (χ 2=5.455, P=0.02). There was no statistically significant difference in blood uric acid levels and liver and kidney function indicators between the two groups before treatment (all P>0.05). After treatment, both groups showed significant improvement in blood uric acid levels and liver and kidney function indicators compared to before treatment (all P<0.05). The levels of blood uric acid and liver and kidney function indicators in the observation group were significantly better than those in the control group after treatment (all P<0.05). The incidence of adverse events in the observation group during treatment was lower than that in the control group (χ 2=5.192, P=0.023). Conclusions:Allopurinol has a certain therapeutic effect on stable coronary heart disease with asymptomatic hyperuricemia, which helps patients enhance their physical activity and reduce the incidence of cardiovascular events.

Objective:To investigate the efficacy and safety of allopurinol in stable coronary heart disease patients with asymptomatic hyperuricemia (AH).Methods:Sixty stable coronary heart disease with AH patients admitted to the Changsha Third Hospital from January 2022 to December 2023 were selected. Patients were randomly divided into an observation group (allopurinol treatment group) and a control group (placebo group). The results of tablet exercise tests, treatment efficacy, blood uric acid levels, liver and kidney function indicators, and incidence of adverse events were compare and analyzed between two groups of patients.Results:The observation group had better exercise termination time, maximum ST descent time, and ST recovery time than the control group (all P<0.05). The total effective rate of the observation group after 6 weeks of treatment was significantly higher than that of the control group, and the difference was statistically significant (χ 2=5.455, P=0.02). There was no statistically significant difference in blood uric acid levels and liver and kidney function indicators between the two groups before treatment (all P>0.05). After treatment, both groups showed significant improvement in blood uric acid levels and liver and kidney function indicators compared to before treatment (all P<0.05). The levels of blood uric acid and liver and kidney function indicators in the observation group were significantly better than those in the control group after treatment (all P<0.05). The incidence of adverse events in the observation group during treatment was lower than that in the control group (χ 2=5.192, P=0.023). Conclusions:Allopurinol has a certain therapeutic effect on stable coronary heart disease with asymptomatic hyperuricemia, which helps patients enhance their physical activity and reduce the incidence of cardiovascular events.

Objective:To investigate the short-term efficacy and safety of rituximab (RTX) in children with calcineurin inhibitor (CNI) resistant steroid resistant nephrotic syndrome (SRNS).Methods:A retrospective case analysis was conducted. Thirteen children with CNI resistant SRNS who were regularly treated with RTX (375 mg/m 2 per dose (maximum dose 500 mg), 1 dose per week, a total of 4 doses) in Department of Nephrology, Children′s Hospital of Fudan University from January 2016 to December 2023 were enrolled. The general data, disease related information, urinary protein/creatinine, serum albumin, blood creatinine before RTX treatment, immunosuppressants, adverse events, and monthly urinary protein/creatinine, serum albumin, and blood creatinine indexes within 6 months after RTX treatment were collected. The changes of urinary protein/creatinine, serum albumin and estimated glomerular filtration rate (eGFR) before and after RTX at 3 and 6 months were analyzed by using paired sample t test and Wilcoxon signed-rank test. Results:Among the 13 patients, 8 were male and 5 were female. The age of disease onset was 4.0 (2.9, 6.8) years and the age of RTX treatment was 9.8 (5.9, 13.6) years. There were 8 cases of focal segmental glomerulosclerosis, 3 cases of minimal change disease and 2 cases of mesangial proliferative glomerulonephritis. No clinically significant gene variation was detected in 12 cases and the other one did not receive gene test. Before RTX treatment, 11 cases were in chronic kidney disease stage G1, and 1 case each was in stage G2 and stage G3. Ten children completed 4 doses of RTX treatment, 1 patient completed 3 doses, and 2 patients completed 2 doses. Urinary protein/creatinine in 13 children at 3 and 6 months after RTX treatment was significantly lower than baseline (0.60 (0.13, 2.04), 0.49 (0.28, 1.10) vs. 1.44 (0.76, 4.11) mg/mg, Z=-2.34, -2.34, both P<0.05), and serum albumin was significantly higher than baseline ((35±8), (34±7) vs. (30±6) g/L, t=2.30, 2.60, both P<0.05). The eGFR at 6 months after RTX treatment was not significantly different from the baseline ((110±32) vs. (113±35) ml/(min·1.73 m 2), t=-0.76, P>0.05)). No serious adverse reactions occurred in this study. Conclusion:RTX could reduce urinary protein and increase serum albumin in short-term treatment in children with CNI resistant SRNS without significant side effects.

Objective This study aims to investigate the selection intention of nursing interns and their influencing fac-tors,providing a scientific basis for nursing human resource management in hospitals and departments.Methods A convenience sampling method was used to conduct a questionnaire survey A questionnaire survey was conducted concerning the selection inten-tion on departments and influencing factors of intern nurses from several tertiary hospitals affiliated to three medical universities from July 2022 to December 2023.General data investigation and self-developed scales were employed,and descriptive analysis,chi-square test and other statistical methods were used to analyze the differences in department selection and related influencing factors among nursing interns.Results Analysis of 652 valid questionnaires revealed that surgery(65.80％)and operating room(38.84％)were the most preferred departments for nursing interns.The primary influencing factors included the working environment and equipment of the department(54.60％),as well as its cohesion and cultural atmosphere(51.53％).Pediat-rics(51.23％)and infectious medicine(48.77％)were found to be less favored by nursing interns.Their main concerns re-volved around work-related risks and population characteristics of patients(67.02％),along with work pressure and labor intensi-ty(65.49％).Epidemic factors have an impact on the attitudes and expectations of nursing interns towards their future practice(P＜0.01).Conclusion The choice of departments by nursing interns is influenced by various environmental,societal and personal factors;primarily based on departmental environment quality and team culture atmosphere considerations.During the in-ternship,nursing interns require more professional education guidance from both hospital administration and individual depart-ments in order to make informed career choices and plans.

Objective To observe the effect of Renshen(ginseng)-Yuzhu(fragrant solomonseal rhizome)on inflammatory factors and inflammasomes in depression rats,and to explore the antidepressant mechanism of Renshen-Yuzhu.Methods Fifty male SD rats were divided into the blank group,model group,fluoxetine group(2.1 mg/kg),Renshen-Yuzhu low-dose group(1.89 g/kg),and Renshen-Yuzhu high-dose group(5.67 g/kg),with ten rats in each group.Except for the blank group,the rats in the other groups were treated with chronic unpredictable mild stress to establish a depression rat model.On the second day after the end of modeling,the rats in each group were given the corresponding drugs once daily for 14 days.After modeling and dosing,body weight,forced swimming immobility time,and sucrose preference rate were measured.After dosing,hematoxylin-eosin staining was used to detect neuronal damage in the cerebral cortex,enzyme-linked immunosorbent assay was used to detect the contents of interleukin-4(IL-4),interleukin-23(IL-23),and interleukin-27(IL-27)in cortex,real-time PCR was used to detect the mRNA expression of interleukin-24(IL-24)in cortex,and the protein expressions of nucleotide-binding oligomerization domain-like receptor protein 1(NLRP1),absent in melanoma 2(AIM2),and nucleotide-binding oligomerization domain-like receptor protein 4(NLRC4)were detected by Western blotting.Results After dosing,compared with the blank group,the body weight of the model group decreased,the sucrose preference rate decreased,the swimming immobility time was prolonged,the neuronal tissue in cortex was destroyed,the content of IL-4 in cortex decreased,the contents of IL-23 and IL-27 in cortex increased,and the protein expressions of NLRP1,AIM2 and NLRC4 in cortex increased(P＜0.01).Compared with the model group,the body weight of rats in each administration group increased,the sucrose preference rate increased,the swimming immobility time was shortened,the damage of neuronal tissues in cortex improved,the content of IL-4 in cortex increased,the contents of IL-23 and IL-27 in cortex decreased,and the protein expressions of NLRP 1,AIM2 and NLRC4 in cortex decreased(P＜0.05).Conclusion Renshen-Yuzhu couplet medicines can improve the depressive-like behavior and exert antidepressant effect in chronic stress rats,and its mechanism may be related to the inhibition of NLRP 1,NLRC4,AIM2 inflammasome activation and its mediated inflammatory response in cortex,reducing pro-inflammatory cytokines,and increasing the level of antiinflammatory cytokines.

Objective This study aims to investigate the selection intention of nursing interns and their influencing fac-tors,providing a scientific basis for nursing human resource management in hospitals and departments.Methods A convenience sampling method was used to conduct a questionnaire survey A questionnaire survey was conducted concerning the selection inten-tion on departments and influencing factors of intern nurses from several tertiary hospitals affiliated to three medical universities from July 2022 to December 2023.General data investigation and self-developed scales were employed,and descriptive analysis,chi-square test and other statistical methods were used to analyze the differences in department selection and related influencing factors among nursing interns.Results Analysis of 652 valid questionnaires revealed that surgery(65.80％)and operating room(38.84％)were the most preferred departments for nursing interns.The primary influencing factors included the working environment and equipment of the department(54.60％),as well as its cohesion and cultural atmosphere(51.53％).Pediat-rics(51.23％)and infectious medicine(48.77％)were found to be less favored by nursing interns.Their main concerns re-volved around work-related risks and population characteristics of patients(67.02％),along with work pressure and labor intensi-ty(65.49％).Epidemic factors have an impact on the attitudes and expectations of nursing interns towards their future practice(P＜0.01).Conclusion The choice of departments by nursing interns is influenced by various environmental,societal and personal factors;primarily based on departmental environment quality and team culture atmosphere considerations.During the in-ternship,nursing interns require more professional education guidance from both hospital administration and individual depart-ments in order to make informed career choices and plans.

Objective:To analyze the clinical and prognosis of children with kidney retransplantation.Methods:Clinical data of 11 children who underwent kidney retransplantation from January 2011 to December 2020 in Department of Nephrology, Children′s Hospital of Fudan University were retrospectilely analyzed. The clinical data including demographic parameters, primary diagnosis, characteristics in the follow-up of renal allograft were analyzed.Results:Totally 11 cases received secondary renal transplantation (male 6, female 5). They were initially diagnosed with chronic kidney disease at the age of 11.9 (7.4, 13.3) years. The median duration of dialysis was 22.1 (3.5, 36.5) months. In the first transplantation, recipient age was 13.9 (11.1, 15.2) years. Ten cases received donation from cardiac death donor (DCD) (9 cases received donors aged less than one year, 5 of them received whole kidney transplantation and one case received donor aged one to three years) and 1 case with living-related donor. Ten graft failures occurred within 1 month after renal transplantation and the other one occurred at the fifth month after transplantation. The causes included vascular factors (9 cases), rejection (1 case) and primary non-function (1 case). In the second transplantation, recipient age was 14.7 (11.7, 16.2) years. All the 11 children received dialysis (7 with PD and 4 with HD) and successfully completed the second transplantation. The median time between the two transplants was 210 (16, 1 041) days. Donors were all DCD donors from 3 years of age or older. The mean follow-up duration was (42±15) months. The estimated glomerular filtration rate was (85±34)ml/(min·1.73 m 2) when the last investigation after kidney retransplantation with the kidney and patient all survived. Conclusions:Kidney retransplantation may have better prognosis in children. Dialysis transition during waiting period and DCD donor from 3 years of age or older can effectively ensure the success of kidney retransplantation.